S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in
NASDAQ:TVTY

Tivity Health Stock Forecast, Price & News

$23.80
+0.37 (+1.58 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$23.11
Now: $23.80
$24.58
50-Day Range
$20.26
MA: $22.69
$24.80
52-Week Range
$1.92
Now: $23.80
$25.45
Volume565,693 shs
Average Volume540,042 shs
Market Capitalization$1.16 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.49
Tivity Health, Inc. provides fitness, nutrition, and social connection solutions in the United States. It operates through two segments, Healthcare and Nutrition. The Healthcare segment offers SilverSneakers senior fitness program to the members of Medicare advantage and Medicare supplement programs; Prime fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The Nutrition segment provides weight management products and services under the Nutrisystem, South Beach Diet, and Wisely Well names. This segment sells pre-packaged foods comprising frozen and non-frozen, and shelf-stable products directly to weight loss program participants primarily through the Internet and telephone; QVC, a television shopping network; and retailers. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.
Tivity Health logo

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:TVTY
CUSIP42224510
Phone800-869-5311
Employees1,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.13 billion
Cash Flow$3.67 per share
Book Value$4.73 per share

Profitability

Net Income$-286,820,000.00

Miscellaneous

Market Cap$1.16 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.04 out of 5 stars

Medical Sector

975th out of 1,960 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

11th out of 25 stocks

Analyst Opinion: 1.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$23.80
+0.37 (+1.58 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for TVTY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tivity Health (NASDAQ:TVTY) Frequently Asked Questions

Is Tivity Health a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Tivity Health stock.
View analyst ratings for Tivity Health
or view top-rated stocks.

What stocks does MarketBeat like better than Tivity Health?

Wall Street analysts have given Tivity Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tivity Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Tivity Health's next earnings date?

Tivity Health is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Tivity Health
.

How were Tivity Health's earnings last quarter?

Tivity Health, Inc. (NASDAQ:TVTY) posted its quarterly earnings data on Wednesday, February, 24th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.31 by $0.07. Tivity Health had a positive trailing twelve-month return on equity of 128.43% and a negative net margin of 47.44%.
View Tivity Health's earnings history
.

How has Tivity Health's stock price been impacted by Coronavirus?

Tivity Health's stock was trading at $7.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TVTY shares have increased by 201.3% and is now trading at $23.80.
View which stocks have been most impacted by COVID-19
.

What guidance has Tivity Health issued on next quarter's earnings?

Tivity Health issued an update on its FY 2021 After-Hours earnings guidance on Wednesday, February, 24th. The company provided EPS guidance of 1.47-1.56 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.36. The company issued revenue guidance of $455-485 million, compared to the consensus revenue estimate of $640.66 million.

What price target have analysts set for TVTY?

8 brokers have issued 1 year price objectives for Tivity Health's shares. Their forecasts range from $11.00 to $32.00. On average, they expect Tivity Health's stock price to reach $22.13 in the next year. This suggests that the stock has a possible downside of 7.0%.
View analysts' price targets for Tivity Health
or view top-rated stocks among Wall Street analysts.

Who are Tivity Health's key executives?

Tivity Health's management team includes the following people:
  • Mr. Adam C. Holland, Chief Financial Officer (Age 42, Pay $527.16k)
  • Mr. Steven Janicak, Division Pres of Healthcare (Age 61, Pay $632.13k)
  • Mr. Richard M. Ashworth, Pres, CEO & Director (Age 46)
  • Mr. Tommy Lewis, Chief Operating Officer
  • Mr. Ryan Wagers, Chief Accounting Officer & Controller (Age 43)
  • Mr. Ray Bilbao, Chief Legal Officer & Corp. Sec.
  • Jill Meyer, VP of Corp. Communications
  • Ms. Bonnie Schirato, Chief People & Culture Officer
  • Ms. Janet Calhoun, Chief Experience Officer
  • Mr. Paul Otto Wimer, Chief Experience Officer (Age 56)

What is Richard Ashworth's approval rating as Tivity Health's CEO?

8 employees have rated Tivity Health CEO Richard Ashworth on Glassdoor.com. Richard Ashworth has an approval rating of 36% among Tivity Health's employees. This puts Richard Ashworth in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Tivity Health's key competitors?

What other stocks do shareholders of Tivity Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include NVIDIA (NVDA), Energy Transfer (ET), Pfizer (PFE), Advanced Micro Devices (AMD), AT&T (T), (CGC), Sorrento Therapeutics (SRNE), Applied Materials (AMAT), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

What is Tivity Health's stock symbol?

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Who are Tivity Health's major shareholders?

Tivity Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.84%), Morgan Stanley (3.73%), JPMorgan Chase & Co. (2.01%), SummerHaven Investment Management LLC (1.49%), The Manufacturers Life Insurance Company (1.47%) and Hawk Ridge Capital Management LP (1.35%). Company insiders that own Tivity Health stock include Bradley S Karro, Ira Sochet, Kevin Wills, Lee Shapiro and Sara Finley.
View institutional ownership trends for Tivity Health
.

Which institutional investors are selling Tivity Health stock?

TVTY stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Principal Financial Group Inc., Voloridge Investment Management LLC, Engineers Gate Manager LP, Tudor Investment Corp Et Al, Public Sector Pension Investment Board, Northern Trust Corp, and Bank of New York Mellon Corp.
View insider buying and selling activity for Tivity Health
or view top insider-selling stocks.

Which institutional investors are buying Tivity Health stock?

TVTY stock was bought by a variety of institutional investors in the last quarter, including SummerHaven Investment Management LLC, The Manufacturers Life Insurance Company , Hawk Ridge Capital Management LP, Victory Capital Management Inc., JPMorgan Chase & Co., Magnetar Financial LLC, BlackRock Inc., and Renaissance Technologies LLC. Company insiders that have bought Tivity Health stock in the last two years include Bradley S Karro, Ira Sochet, Kevin Wills, Lee Shapiro, and Sara Finley.
View insider buying and selling activity for Tivity Health
or or view top insider-buying stocks.

How do I buy shares of Tivity Health?

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tivity Health's stock price today?

One share of TVTY stock can currently be purchased for approximately $23.80.

How much money does Tivity Health make?

Tivity Health has a market capitalization of $1.16 billion and generates $1.13 billion in revenue each year. The company earns $-286,820,000.00 in net income (profit) each year or $2.02 on an earnings per share basis.

How many employees does Tivity Health have?

Tivity Health employs 1,000 workers across the globe.

What is Tivity Health's official website?

The official website for Tivity Health is www.tivityhealth.com.

Where are Tivity Health's headquarters?

Tivity Health is headquartered at 701 Cool Springs Boulevard, Franklin TN, 37067.

How can I contact Tivity Health?

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 800-869-5311 or via email at [email protected]


This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.